{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:28:38Z","timestamp":1793863718416,"version":"4.6.1"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T00:00:00Z","timestamp":1786752000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Translational Autoimmunity"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jtauto.2026.100395","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:29:59Z","timestamp":1787239799000},"page":"100395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities"],"prefix":"10.1016","volume":"13","author":[{"given":"Afsaneh","family":"Enteshari-Moghaddam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4670-7127","authenticated-orcid":false,"given":"Mitra","family":"Abbasifard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ard.2025.10.022","article-title":"Implications of population ageing for the burden and cost of musculoskeletal conditions: insights from a global burden of disease decomposition and economic analysis, 1990-2021","volume":"85","author":"Briggs","year":"2026","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100395_bib2","series-title":"The Palgrave Encyclopedia of Disability","first-page":"1","article-title":"Osteoarthritis: pathophysiology and classification of a common disabling condition","author":"O'Sullivan","year":"2024"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70727","article-title":"Osteoarthritis: epidemiology, pathogenesis, and treatment","volume":"7","author":"Chen","year":"2026","journal-title":"MedComm"},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/art.42089","article-title":"Prevalence trends of site\u2010specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019","volume":"74","author":"Long","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.joca.2020.01.002","article-title":"Osteoarthritis year in review 2019: epidemiology and therapy","volume":"28","author":"Kloppenburg","year":"2020","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","article-title":"The role of synovitis in osteoarthritis pathogenesis","volume":"51","author":"Scanzello","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13075-017-1229-9","article-title":"Synovitis in osteoarthritis: current understanding with therapeutic implications","volume":"19","author":"Mathiessen","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100395_bib10","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib11","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.ard.2026.03.010","article-title":"RA and PsA synovial tissue single-cell analysis demonstrates differential fibroblast populations with distinct phenotypes and functional capacities","volume":"85","author":"Tynan","year":"2026","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100395_bib12","series-title":"Transcriptomic and Glycobiological Profiling of Synovial Fibroblasts in Rheumatoid Arthritis: the Role of Sialylation in fibroblast-macrophage Crosstalk","author":"Cil","year":"2026"},{"key":"10.1016\/j.jtauto.2026.100395_bib13","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.2147\/DDDT.S295224","article-title":"The development of disease-modifying therapies for osteoarthritis (DMOADs): the evidence to date","author":"Oo","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib14","doi-asserted-by":"crossref","DOI":"10.5812\/aapm.89990","article-title":"Efficacy of methotrexate on pain severity reduction and improvement of quality of life in patients with moderate to severe knee osteoarthritis","volume":"9","author":"Enteshari-Moghaddam","year":"2019","journal-title":"Anesthesiol. Pain Med."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib15","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s10067-019-04573-7","article-title":"Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis","volume":"38","author":"Enteshari-Moghaddam","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib16","article-title":"A comprehensive review of the pathophysiology and management of osteoarthritis: emerging therapeutic strategies and clinical insights","volume":"18","author":"Kerketta","year":"2026","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12889-025-25427-9","article-title":"Cost-effectiveness analysis of surgical and non-surgical weight loss interventions in end-stage knee osteoarthritis and obesity: a Markov state model","volume":"26","author":"Panunzi","year":"2026","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jtauto.2026.100395_bib18","doi-asserted-by":"crossref","first-page":"e977","DOI":"10.61919\/kypjww22","article-title":"Medical and surgical management of osteoarthritis of knees","author":"Javed","year":"2025","journal-title":"J. Health Wellness Community Res."},{"key":"10.1016\/j.jtauto.2026.100395_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1387651","article-title":"Harmonizing hope: navigating the osteoarthritis melody through the CCL2\/CCR2 axis for innovative therapeutic avenues","volume":"15","author":"Abbasifard","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib20","article-title":"Histological and morphological changes in the synovial membrane in experimental models of osteoarthritis","volume":"1","author":"Beknazarov","year":"2026","journal-title":"Shokh Articles Library"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41584-025-01223-y","article-title":"The role of the immune system in osteoarthritis: mechanisms, challenges and future directions","volume":"21","author":"Moulin","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"issue":"17","key":"10.1016\/j.jtauto.2026.100395_bib22","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.3390\/ijms22179208","article-title":"Cytokines and chemokines involved in osteoarthritis pathogenesis","volume":"22","author":"Molnar","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s42358-024-00351-5","article-title":"Role of Interleukin-17 family cytokines in disease severity of patients with knee osteoarthritis","volume":"64","author":"Kamiab","year":"2024","journal-title":"Adv. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2022.100200","article-title":"Proteomics profiling of human synovial fluid suggests increased protein interplay in early-osteoarthritis (OA) that is lost in late-stage OA","volume":"21","author":"Ali","year":"2022","journal-title":"Mol. Cell. Proteomics"},{"issue":"11","key":"10.1016\/j.jtauto.2026.100395_bib25","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00256-025-04908-3","article-title":"Recent evolution in imaging techniques for assessment of synovitis in osteoarthritis","volume":"54","author":"Hayashi","year":"2025","journal-title":"Skelet. Radiol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/jmri.28223","article-title":"Impact of sustained synovitis on knee joint structural degeneration: 4\u2010year MRI data from the osteoarthritis initiative","volume":"57","author":"Ramezanpour","year":"2023","journal-title":"J. Magn. Reson. Imag."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib27","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1136\/ard.2011.150243","article-title":"Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study","volume":"70","author":"Roemer","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100395_bib28","article-title":"In silico modeling of osteochondral pathophysiology and regeneration","author":"Lesage","year":"2021","journal-title":"Ident. Molecular Signatures Therapeut. Targets with Mechanistic. Data-Driven Network Models"},{"key":"10.1016\/j.jtauto.2026.100395_bib29","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X231177116","article-title":"Emerging molecular biomarkers in osteoarthritis pathology","volume":"15","author":"Sandhu","year":"2023","journal-title":"Ther. Adv. Musculoskel. Dis."},{"key":"10.1016\/j.jtauto.2026.100395_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1334479","article-title":"Mendelian randomization and transcriptome analysis identified immune-related biomarkers for osteoarthritis","volume":"15","author":"Pang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.jtauto.2026.100395_bib31","first-page":"237","article-title":"The role of cytokines in osteoarthritis pathophysiology","volume":"39","author":"Fernandes","year":"2002","journal-title":"Biorheology"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/rheumato5040017","article-title":"Emerging AI-and biomarker-driven precision medicine in autoimmune rheumatic diseases: from diagnostics to therapeutic decision-making","volume":"5","author":"Al-Ewaidat","year":"2025","journal-title":"Rheumato"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.31138\/mjr.30.4.216","article-title":"Association between serum vitamin D deficiency and knee osteoarthritis","volume":"30","author":"Anari","year":"2019","journal-title":"Mediterr. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib34","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.joca.2021.11.014","article-title":"Joint synovial macrophages as a potential target for intra-articular treatment of osteoarthritis-related pain","volume":"30","author":"Wang","year":"2022","journal-title":"Osteoarthr. Cartil."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42881","article-title":"Advances in research on M1\/M2 macrophage polarization in the pathogenesis and treatment of osteoarthritis","volume":"11","author":"Deng","year":"2025","journal-title":"Heliyon"},{"key":"10.1016\/j.jtauto.2026.100395_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1694625","article-title":"A critical guideline for controlling monocyte-derived macrophages phenotypes","volume":"16","author":"Moschetti","year":"2026","journal-title":"Front. Immunol."},{"issue":"7771","key":"10.1016\/j.jtauto.2026.100395_bib37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41586-019-1471-1","article-title":"Locally renewing resident synovial macrophages provide a protective barrier for the joint","volume":"572","author":"Culemann","year":"2019","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1089\/dna.2022.0509","article-title":"A single-cell RNA-sequencing analysis of distinct subsets of synovial macrophages in rheumatoid arthritis","volume":"42","author":"Li","year":"2023","journal-title":"DNA Cell Biol."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib39","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s10067-026-08030-0","article-title":"Single-cell RNA sequencing unravels chondrocyte heterogeneity and immune cell interactions in knee osteoarthritis pathogenesis","volume":"45","author":"Li","year":"2026","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12951-026-04258-9","article-title":"Photothermal reprogramming of synovial M1 macrophages reshapes the pro-inflammatory microenvironment to reverse temporomandibular joint osteoarthritis","volume":"24","author":"Wang","year":"2026","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jtauto.2026.100395_bib41","doi-asserted-by":"crossref","DOI":"10.1177\/1179544117751430","article-title":"Osteoarthritis and the complement cascade","volume":"11","author":"Silawal","year":"2018","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"10.1016\/j.jtauto.2026.100395_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.957800","article-title":"The role of C5a-C5aR1 axis in bone pathophysiology: a mini-review","volume":"10","author":"Ruocco","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11926-013-0323-5","article-title":"Synovium and the innate inflammatory network in osteoarthritis progression","volume":"15","author":"Liu-Bryan","year":"2013","journal-title":"Curr. Rheumatol. Rep."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib44","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41584-022-00749-9","article-title":"Synovial inflammation in osteoarthritis progression","volume":"18","author":"Sanchez-Lopez","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100395_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890094","article-title":"Sex-differences and associations between complement activation and synovial vascularization in patients with late-stage knee osteoarthritis","volume":"13","author":"Sodhi","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s42003-024-06051-6","article-title":"Inhibition of complement C3 prevents osteoarthritis progression in Guinea pigs by blocking STAT1 activation","volume":"7","author":"Xu","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jtauto.2026.100395_bib47","series-title":"Therapeutic Inhibition of Complement Component 3 in Spontaneous Osteoarthritis","author":"Xu","year":"2024"},{"issue":"12","key":"10.1016\/j.jtauto.2026.100395_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189017","article-title":"C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid","volume":"12","author":"Hornum","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtauto.2026.100395_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2022.170815","article-title":"Involvement of complement peptides C3a and C5a in osteoarthritis pathology","volume":"154","author":"Sch\u00e4fer","year":"2022","journal-title":"Peptides"},{"key":"10.1016\/j.jtauto.2026.100395_bib50","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.2147\/JIR.S514002","article-title":"Osteoimmunology in osteoarthritis: unraveling the interplay of immunity, inflammation, and joint degeneration","author":"Hu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.jtauto.2026.100395_bib51","first-page":"356","article-title":"T cells in osteoarthritis: alterations and beyond","volume":"8","author":"Li","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100395_bib52","series-title":"Phenotype and Function of Proinflammatory T Helper 17 Cells and Immunosuppressive Regulatory T Cells in the Pathobiology of Early Osteoarthritis","author":"Keller","year":"2021"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib53","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/cells9030549","article-title":"CD4+ FOXP3+ T cells in rheumatoid arthritis bone marrow are partially impaired","volume":"9","author":"Massalska","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/art.22272","article-title":"Where FoxP3\u2010dependent regulatory T cells impinge on the development of inflammatory arthritis","volume":"56","author":"Nguyen","year":"2007","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib55","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-024-01190-w","article-title":"The \u2018treg paradox\u2019in inflammatory arthritis","volume":"21","author":"Schnell","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaci.2023.09.025","article-title":"Regulatory T cells in dominant immunological tolerance","volume":"153","author":"Peter Georgiev","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jtauto.2026.100395_bib57","article-title":"Cell-based therapies for rheumatoid arthritis: opportunities and challenges","volume":"14","author":"Li","year":"2022","journal-title":"Therapeut. Adv. Muscoskel. Dis."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib58","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.joca.2009.03.002","article-title":"Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix","volume":"17","author":"Loeser","year":"2009","journal-title":"Osteoarthr. Cartil."},{"issue":"22","key":"10.1016\/j.jtauto.2026.100395_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216468","article-title":"Inflammatory and metabolic signaling interfaces of the hypertrophic and senescent chondrocyte phenotypes associated with osteoarthritis","volume":"24","author":"Horv\u00e1th","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2026.100395_bib60","series-title":"Role of DNA Damage and Cellular Senescence in Osteoarthritis Pathophysiology","author":"Copp","year":"2023"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.spinee.2024.09.017","article-title":"Senolytics cocktail dasatinib and quercetin alleviate chondrocyte senescence and facet joint osteoarthritis in mice","volume":"25","author":"Zhao","year":"2025","journal-title":"Spine J."},{"key":"10.1016\/j.jtauto.2026.100395_bib62","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14361","article-title":"Senolytic therapy combining dasatinib and quercetin restores the chondrogenic phenotype of human osteoarthritic chondrocytes by the release of pro\u2010anabolic mediators","volume":"24","author":"Maurer","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.jtauto.2026.100395_bib64","first-page":"42","article-title":"Remodeling of senescent macrophages in synovium alleviates trauma-and aging-induced osteoarthritis","volume":"55","author":"Liu","year":"2026","journal-title":"Bioact. Mater."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100395_bib65","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200309","article-title":"Senescent cells and macrophages: key players for regeneration?","volume":"10","author":"Elder","year":"2020","journal-title":"Open Biol."},{"key":"10.1016\/j.jtauto.2026.100395_bib66","article-title":"Mechanisms of synovial macrophage polarization in osteoarthritis pathogenesis and their therapeutic implications","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jtauto.2026.100395_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1269724","article-title":"Macrophage polarization in osteoarthritis progression: a promising therapeutic target","volume":"11","author":"Zhang","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib68","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.arthro.2022.02.009","article-title":"Acute intervention with selective interleukin-1 inhibitor therapy may reduce the progression of posttraumatic osteoarthritis of the knee: a systematic review of current evidence","volume":"38","author":"Aman","year":"2022","journal-title":"Arthrosc. J. Arthrosc. Relat. Surg."},{"key":"10.1016\/j.jtauto.2026.100395_bib69","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2147\/DMSO.S520465","article-title":"Is it time to revisit the role of interleukin-1 inhibitors in osteoarthritis?","author":"Brom","year":"2025","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib70","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.3390\/jcm13102859","article-title":"Efficacy of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials from the years 2000 to 2023","volume":"13","author":"Knapik","year":"2024","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib71","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double\u2010blind, placebo\u2010controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Care Res."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib72","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2165\/11599350-000000000-00000","article-title":"Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review","volume":"29","author":"Jotanovic","year":"2012","journal-title":"Drugs Aging"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib73","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/03635465251401225","article-title":"Intra-articular delivery of recombinant Interleukin-1 receptor antagonist protein (Anakinra) enhances graft function in a porcine model of osteochondral repair","volume":"54","author":"Stoeckl","year":"2026","journal-title":"Am. J. Sports Med."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib74","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.joca.2025.12.018","article-title":"Engineered cationic Interleukin-1 receptor antagonist outperforms anakinra at joint retention and preventing IL-1-induced cartilage inflammation","volume":"34","author":"Boyer","year":"2025","journal-title":"Osteoarthr. Cartil."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib75","first-page":"1317","article-title":"Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study","volume":"32","author":"Chevalier","year":"2005","journal-title":"J. Rheumatol."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib76","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/M20-0527","article-title":"Effects of interleukin-1\u03b2 inhibition on incident hip and knee replacement: exploratory analyses from a randomized, double-blind, placebo-controlled trial","volume":"173","author":"Schieker","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib78","article-title":"Extracellular vesicles in osteoarthritis synovial fluid contain both transmembrane and intravesical TNF-\u03b1","volume":"7","author":"Zhang","year":"2025","journal-title":"Osteoarthr. Cartil. Open"},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib79","doi-asserted-by":"crossref","first-page":"10216","DOI":"10.1021\/acs.jmedchem.5c00394","article-title":"Identification of a RANKL\/TNF-\u03b1 dual-inhibitor as a potential disease-modifying agent for the treatment of knee osteoarthritis","volume":"68","author":"Shao","year":"2025","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib81","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/cells14070489","article-title":"TNF-alpha inhibitor prevents cigarette smoke extract-induced cell death in osteoarthritis-derived chondrocytes in culture","volume":"14","author":"Levy","year":"2025","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib82","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/ard.2011.149849","article-title":"Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification","volume":"71","author":"Verbruggen","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib83","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","article-title":"A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis\u2013the HUMOR trial","volume":"26","author":"Aitken","year":"2018","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib84","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/annrheumdis-2016-209757","article-title":"Systemic inhibition of IL-6\/Stat3 signalling protects against experimental osteoarthritis","volume":"76","author":"Latourte","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib86","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jor.23262","article-title":"Harpagoside suppresses IL\u20106 expression in primary human osteoarthritis chondrocytes","volume":"35","author":"Haseeb","year":"2017","journal-title":"J. Orthop. Res."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib87","doi-asserted-by":"crossref","first-page":"9767","DOI":"10.1038\/s41467-025-64710-6","article-title":"Safety and immunogenicity of PPV-06, an active anti-IL-6 immunotherapy targeting low-grade inflammation against knee osteoarthritis: a randomized, double-blind, placebo-controlled, clinical phase 1 study","volume":"16","author":"Rannou","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jtauto.2026.100395_bib88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/annrheumdis-2024-eular.LBA136","article-title":"LBA0011 safety and immunogenicity of an active ANTI-IL-6 immunotherapy in a phase 1 clinical trial in knee osteoarthritis patients","volume":"83","author":"Rannou","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2020-218547","article-title":"Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial","volume":"80","author":"Richette","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib93","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13018-025-05503-x","article-title":"Pain mediator NGF improves chondrocyte extracellular matrix synthesis via PI3K\/AKT pathway","volume":"20","author":"Wang","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib94","doi-asserted-by":"crossref","first-page":"eadi5501","DOI":"10.1126\/sciadv.adi5501","article-title":"Nanoparticle-based inhibition of vascular endothelial growth factor receptors alleviates osteoarthritis pain and cartilage damage","volume":"10","author":"Ma","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib95","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12891-017-1792-x","article-title":"Efficacy of nerve growth factor antibody in a knee osteoarthritis pain model in mice","volume":"18","author":"Miyagi","year":"2017","journal-title":"BMC Muscoskelet. Disord."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib96","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.joca.2015.02.002","article-title":"Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis","volume":"23","author":"Ishikawa","year":"2015","journal-title":"Osteoarthr. Cartil."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib99","doi-asserted-by":"crossref","DOI":"10.1177\/23259671221088590","article-title":"Efficacy and safety of anti\u2013nerve growth factor antibody therapy for hip and knee osteoarthritis: a meta-analysis","volume":"10","author":"Gao","year":"2022","journal-title":"Orthop. J. Sports Med."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib77","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2217\/imt.10.67","article-title":"Anti-TNF-\u03b1 agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls","volume":"2","author":"Silva","year":"2010","journal-title":"Immunotherapy"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrrheum.2015.169","article-title":"TNF biology, pathogenic mechanisms and emerging therapeutic strategies","volume":"12","author":"Kalliolias","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib85","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1093\/rheumatology\/keaa248","article-title":"A roadmap to target interleukin-6 in osteoarthritis","volume":"59","author":"Wiegertjes","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jtauto.2026.100395_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2025.111666","article-title":"MicroRNA-146a-3p as an alternative to anti-IL-6 monoclonal antibody therapy: Intra-articular liposome delivery for osteoarthritis treatment","volume":"200","author":"Wu","year":"2025","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib91","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajpath.2023.10.005","article-title":"IL-6 reduces spheroid sizes of osteophytic cells derived from osteoarthritis knee joint via induction of apoptosis","volume":"194","author":"Negishi","year":"2024","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib92","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/nrrheum.2012.80","article-title":"Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis","volume":"8","author":"Mapp","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100395_bib97","article-title":"Study on the analgesic and anti-inflammatory mechanisms of Jingu Zhitong gel in the treatment of knee osteoarthritis through the IL-17, NGF-TrkA, and COX-2\/PGE2 pathways","volume":"17","author":"Li","year":"2026","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib98","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ejp.1478","article-title":"The COX\u20102 inhibitor etoricoxib reduces experimental osteoarthritis and nociception in rats: the roles of TGF\u2010\u03b21 and NGF expressions in chondrocytes","volume":"24","author":"Wen","year":"2020","journal-title":"Eur. J. Pain"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13018-025-05679-2","article-title":"Development of a macrophage polarization-modulating therapeutic agent for osteoarthritis treatment","volume":"20","author":"Wu","year":"2025","journal-title":"J. Orthop. Surg. Res."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib101","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/os.13993","article-title":"Emerging roles of macrophage polarization in osteoarthritis: mechanisms and therapeutic strategies","volume":"16","author":"Yuan","year":"2024","journal-title":"Orthop. Surg."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib102","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1186\/s12967-025-07340-2","article-title":"Macrophages: pivotal orchestrators and emerging therapeutic targets in osteoarthritis pathogenesis","volume":"23","author":"Hu","year":"2025","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib103","first-page":"184","article-title":"CD14 and CSF1R as developmental molecular targets for the induction of osteoarthritis","volume":"16","author":"Zheng","year":"2023","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-016-0973-6","article-title":"Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis","volume":"18","author":"Garcia","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jtauto.2026.100395_bib105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.intimp.2019.01.049","article-title":"Oridonin inhibits IL-1\u03b2-induced inflammation in human osteoarthritis chondrocytes by activating PPAR-\u03b3","volume":"69","author":"Jia","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib106","article-title":"PPAR\u2010\u03b3 activation alleviates osteoarthritis through both the Nrf2\/NLRP3 and PGC\u20101\u03b1\/\u0394\u03c8m pathways by inhibiting pyroptosis","volume":"2023","author":"Feng","year":"2023","journal-title":"PPAR Res."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib107","article-title":"PPAR\u03b3 regulates osteoarthritis chondrocytes apoptosis through caspase-3 dependent mitochondrial pathway","volume":"14","author":"Yuan","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70456","article-title":"Pioglitazone regulates chondrocyte metabolism and attenuates osteoarthritis by activating peroxisome proliferator\u2010activated receptor gamma","volume":"29","author":"Shi","year":"2025","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib109","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13018-024-04583-5","article-title":"PDK4 inhibits osteoarthritis progression by activating the PPAR pathway","volume":"19","author":"Li","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib110","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2537348","article-title":"Ultrasound therapy inhibits knee osteoarthritis progression in rabbits by activating the PPARs pathway: a pilot study","volume":"57","author":"Luo","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.jtauto.2026.100395_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110877","article-title":"PPAR \u03b3 activation in chondrocytes alleviates glucocorticoid-induced oxidative stress, mitochondrial impairment, and pyroptosis via autophagic flow enhancement","volume":"390","author":"Wu","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib112","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41467-024-45174-6","article-title":"5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPAR\u03b3 axis","volume":"15","author":"Kim","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib113","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/mr\/roae015","article-title":"lncRNA OIP5-AS1 promotes mitophagy to alleviate osteoarthritis by upregulating PPAR-\u03b3 to activate the AMPK\/Akt\/mTOR pathway","volume":"34","author":"Sun","year":"2024","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100395_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107760","article-title":"Discovery of novel thiazole derivatives containing pyrazole scaffold as PPAR-\u03b3 agonists, \u03b1-glucosidase, \u03b1-amylase and COX-2 inhibitors; design, synthesis and in silico study","volume":"152","author":"Fadaly","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jtauto.2026.100395_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119130","article-title":"Gluteal adipose-derived stem cell exosomes promote macrophage polarization and cartilage regeneration in osteoarthritis via PTPRC modulation","volume":"196","author":"Chen","year":"2026","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib116","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1021\/acsnano.4c16785","article-title":"Remodeling the proinflammatory microenvironment in osteoarthritis through interleukin-1 beta tailored exosome cargo for inflammatory regulation and cartilage regeneration","volume":"19","author":"Chen","year":"2025","journal-title":"ACS Nano"},{"issue":"14","key":"10.1016\/j.jtauto.2026.100395_bib117","article-title":"Inflammatory fibroblast\u2010like synoviocyte\u2010derived exosomes aggravate osteoarthritis via enhancing macrophage glycolysis","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12951-024-02324-8","article-title":"A novel extracellular vesicles production system harnessing matrix homeostasis and macrophage reprogramming mitigates osteoarthritis","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib120","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12967-025-06808-5","article-title":"Exosomes derived from hypoxia-preconditioned M2 macrophages alleviate degeneration in knee osteoarthritis through the miR-124-3p\/STAT3 axis","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jtauto.2026.100395_bib121","article-title":"Therapeutic effects of hypoxia-preconditioned cartilage progenitor cell-exosomes on osteoarthritis through autophagy activation and macrophage polarization modulation","author":"Zhou","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib122","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12951-024-02336-4","article-title":"M2 macrophage-derived exosomal miR-26b-5p regulates macrophage polarization and chondrocyte hypertrophy by targeting TLR3 and COL10A1 to alleviate osteoarthritis","volume":"22","author":"Qian","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jtauto.2026.100395_bib123","article-title":"Platelet-rich plasma-derived microRNA let-7a-5p alleviates knee osteoarthritis by regulating macrophage polarization and improving inflammatory microenvironment","volume":"17","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib118","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12773","article-title":"Vitexin alleviates interleukin\u20101\u03b2\u2010induced inflammatory responses in chondrocytes from osteoarthritis patients: involvement of HIF\u20101\u03b1 pathway","volume":"90","author":"Yang","year":"2019","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib124","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/14712598.2024.2446612","article-title":"Clinical updates in mesenchymal stromal cell therapy for osteoarthritis treatment","volume":"25","author":"Im","year":"2025","journal-title":"Expert Opin. Biol. Ther."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/jrms.jrms_515_23","article-title":"Efficacy and safety of mesenchymal stem cell injections for knee osteoarthritis: a systematic review and meta-analysis","volume":"29","author":"Zhang","year":"2024","journal-title":"J. Res. Med. Sci."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib126","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13018-024-04846-1","article-title":"Transplantation of three mesenchymal stem cells for knee osteoarthritis, which cell and type are more beneficial? A systematic review and network meta-analysis","volume":"19","author":"Chen","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib127","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jhps\/hnx011","article-title":"Mesenchymal stem cell therapy in the treatment of hip osteoarthritis","volume":"4","author":"Mardones","year":"2017","journal-title":"J. Hip. preserv. Surgery"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2217\/rme-2018-0161","article-title":"Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial","volume":"14","author":"Freitag","year":"2019","journal-title":"Regen. Med."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100395_bib129","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1097\/TP.0b013e318291a2da","article-title":"Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study","volume":"95","author":"Orozco","year":"2013","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib130","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1097\/TP.0000000000000678","article-title":"Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial","volume":"99","author":"Vega","year":"2015","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib131","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/stem.1634","article-title":"Intra\u2010articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof\u2010of\u2010concept clinical trial","volume":"32","author":"Jo","year":"2014","journal-title":"Stem Cell."},{"key":"10.1016\/j.jtauto.2026.100395_bib132","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.knee.2024.02.004","article-title":"The effects of combined and independent low-level laser and mesenchymal stem cell therapy on induced knee osteoarthritis: an animal study","volume":"47","author":"Tanideh","year":"2024","journal-title":"Knee"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib133","first-page":"1","article-title":"An examination of the effects of stem cell therapy on knee functionality in patients diagnosed with knee osteoarthritis","volume":"19","author":"Menekseoglu","year":"2025","journal-title":"Rev. Gest\u00e3o Soc. e Ambiental"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib134","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/stcltm\/szad088","article-title":"A phase I dose-escalation clinical trial to assess the safety and efficacy of umbilical cord-derived mesenchymal stromal cells in knee osteoarthritis","volume":"13","author":"Matas","year":"2024","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12967-024-05945-7","article-title":"Safety and efficacy of mesenchymal stromal cells mitochondria transplantation as a cell-free therapy for osteoarthritis","volume":"23","author":"Vega-Letter","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jtauto.2026.100395_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123239","article-title":"Hydrogen generators-protected mesenchymal stem cells reverse articular redox imbalance-induced immune dysfunction for osteoarthritis treatment","volume":"320","author":"Xu","year":"2025","journal-title":"Biomaterials"},{"issue":"17","key":"10.1016\/j.jtauto.2026.100395_bib137","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1039\/D4BM00668B","article-title":"FGF18 encoding circular mRNA-LNP based on glycerolipid engineering of mesenchymal stem cells for efficient amelioration of osteoarthritis","volume":"12","author":"Huang","year":"2024","journal-title":"Biomater. Sci."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib138","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jmii.2025.04.003","article-title":"Therapeutic application of regulatory T cell in osteoarthritis","volume":"58","author":"Hsieh","year":"2025","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.jtauto.2026.100395_bib139","article-title":"Metallothionein-1 mitigates the advancement of osteoarthritis by regulating Th17\/Treg balance","volume":"405","author":"Xia","year":"2024","journal-title":"Cell. Immunol."},{"issue":"47","key":"10.1016\/j.jtauto.2026.100395_bib140","doi-asserted-by":"crossref","first-page":"eabo5284","DOI":"10.1126\/sciadv.abo5284","article-title":"Tolerogenic nanoparticles induce type II collagen\u2013specific regulatory T cells and ameliorate osteoarthritis","volume":"8","author":"Sohn","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib141","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.joca.2024.10.003","article-title":"Osteoarthritis year in review 2024: molecular biomarkers of osteoarthritis","volume":"33","author":"Welhaven","year":"2025","journal-title":"Osteoarthr. Cartil."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib142","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1007\/s10067-024-07042-y","article-title":"Inflammation as a therapeutic target for osteoarthritis: a literature review of clinical trials","volume":"43","author":"Zhu","year":"2024","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-025-00594-6","article-title":"The osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib144","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1469-7580.2009.01186.x","article-title":"The anatomical basis for a novel classification of osteoarthritis and allied disorders","volume":"216","author":"McGonagle","year":"2010","journal-title":"J. Anat."},{"issue":"1_suppl","key":"10.1016\/j.jtauto.2026.100395_bib145","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1177\/1947603520942941","article-title":"Synovial fluid biomarkers in knee osteoarthritis: a systematic review and quantitative evaluation using BIPEDs criteria","volume":"13","author":"Boffa","year":"2021","journal-title":"Cartilage"},{"key":"10.1016\/j.jtauto.2026.100395_bib146","series-title":"The Role of Knee Synovium in the Pathophysiology of Osteoarthritis","author":"Jamal","year":"2021"},{"issue":"10","key":"10.1016\/j.jtauto.2026.100395_bib147","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/14737159.2025.2550639","article-title":"Diagnosing, treating and monitoring the inflammatory endotype in osteoarthritis clinical trials","volume":"25","author":"Thudium","year":"2025","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.jtauto.2026.100395_bib148","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221080377","article-title":"Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials","volume":"14","author":"Meng","year":"2022","journal-title":"Ther. Adv. Musculoskel. Dis."},{"key":"10.1016\/j.jtauto.2026.100395_bib149","series-title":"Seminars in Arthritis and Rheumatism","article-title":"Imaging of synovitis in osteoarthritis: current status and outlook","author":"Hayashi","year":"2011"},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib150","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.joca.2011.05.004","article-title":"Evolution of semi-quantitative whole joint assessment of knee OA: MOAKS (MRI osteoarthritis knee score)","volume":"19","author":"Hunter","year":"2011","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib151","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.joca.2015.08.011","article-title":"An illustrative overview of semi-quantitative MRI scoring of knee osteoarthritis: lessons learned from longitudinal observational studies","volume":"24","author":"Roemer","year":"2016","journal-title":"Osteoarthr. Cartil."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib152","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.joca.2017.11.015","article-title":"The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials","volume":"26","author":"Wang","year":"2018","journal-title":"Osteoarthr. Cartil."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib153","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.joca.2022.02.618","article-title":"OA synovial fluid: biological insights into a whole-joint disease","volume":"30","author":"Vincent","year":"2022","journal-title":"Osteoarthr. Cartil."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib154","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/ijms18030601","article-title":"Review of prospects of biological fluid biomarkers in osteoarthritis","volume":"18","author":"Nguyen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib155","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5574582","article-title":"Biomarkers of joint damage in osteoarthritis: current status and future directions","volume":"2021","author":"Kumavat","year":"2021","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.jtauto.2026.100395_bib156","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41584-025-01271-4","article-title":"Synovial fluid as a complex molecular pool contributing to knee osteoarthritis","volume":"21","author":"Peters","year":"2025","journal-title":"Nat. Rev. Rheumatol."},{"issue":"9","key":"10.1016\/j.jtauto.2026.100395_bib157","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.3899\/jrheum.110426","article-title":"Synovial tissue analysis for the discovery of diagnostic and prognostic biomarkers in patients with early arthritis","volume":"38","author":"de Hair","year":"2011","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib158","first-page":"448","article-title":"Serum and synovial fluid concentrations of interleukin-18 and interleukin-20 in patients with osteoarthritis of the knee and their correlation with other markers of inflammation and turnover of joint cartilage","volume":"18","author":"Waszczykowski","year":"2020","journal-title":"Arch. Med. Sci.: AMS"},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib159","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/jfmk7040097","article-title":"The usefulness of synovial fluid proteome analysis in orthopaedics: focus on osteoarthritis and periprosthetic joint infections","volume":"7","author":"Bizzoca","year":"2022","journal-title":"J. Funct. Morphol. Kinesiol."},{"key":"10.1016\/j.jtauto.2026.100395_bib160","first-page":"1130","article-title":"Systematic evaluation of pre-analytical variables on synovial fluid metabolomic profiles using GC-ToF-MS and UHPLC-MS","volume":"151","author":"Ladha","year":"2026"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib161","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.joca.2015.03.002","article-title":"OARSI clinical trials recommendations: soluble biomarker assessments in clinical trials in osteoarthritis","volume":"23","author":"Kraus","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jtauto.2026.100395_bib162","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ebiom.2016.05.004","article-title":"The need for predictive, prognostic, objective and complementary blood-based biomarkers in osteoarthritis (OA)","volume":"7","author":"Bay-Jensen","year":"2016","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib163","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1177\/0004563215610142","article-title":"Elevated erythrocyte sedimentation rate and high-sensitivity C-reactive protein in osteoarthritis of the knee: relationship with clinical findings and radiographic severity","volume":"53","author":"Hanada","year":"2016","journal-title":"Ann. Clin. Biochem."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib164","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/os.70064","article-title":"A review and meta\u2010analysis of biomarkers in early\u2010stage osteoarthritis","volume":"17","author":"Lawrence","year":"2025","journal-title":"Orthop. Surg."},{"issue":"14","key":"10.1016\/j.jtauto.2026.100395_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411655","article-title":"The role of genetics and epigenetic regulation in the pathogenesis of osteoarthritis","volume":"24","author":"Kie\u0142bowski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib166","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/s41584-024-01102-y","article-title":"Molecular biomarker approaches to prevention of post-traumatic osteoarthritis","volume":"20","author":"Kraus","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib167","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/annrheumdis-2019-216055","article-title":"Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease","volume":"79","author":"Attur","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib168","doi-asserted-by":"crossref","DOI":"10.1177\/23094990221076652","article-title":"Interleukin-1 genetic polymorphisms in knee osteoarthritis: what do we know? A meta-analysis and systematic review","volume":"30","author":"Budhiparama","year":"2022","journal-title":"J. Orthop. Surg."},{"issue":"3","key":"10.1016\/j.jtauto.2026.100395_bib169","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/biologics5030027","article-title":"Advancing early detection of osteoarthritis through biomarker profiling and predictive modelling: a review","volume":"5","author":"Coleman","year":"2025","journal-title":"Biologics"},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12891-020-03532-7","article-title":"Quantification of hip effusion-synovitis and its cross-sectional and longitudinal associations with hip pain, MRI findings and early radiographic hip OA","volume":"21","author":"Ahedi","year":"2020","journal-title":"BMC Muscoskelet. Disord."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib171","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/art.21914","article-title":"Identification of synovial biomarkers of response to experimental treatment in early\u2010phase clinical trials in spondylarthritis","volume":"54","author":"Kruithof","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib172","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.joca.2011.02.018","article-title":"Summary and recommendations of the OARSI FDA osteoarthritis assessment of structural change working group","volume":"19","author":"Conaghan","year":"2011","journal-title":"Osteoarthr. Cartil."},{"issue":"7","key":"10.1016\/j.jtauto.2026.100395_bib173","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/art.40840","article-title":"A phase II trial of lutikizumab, an anti\u2013interleukin\u20101\u03b1\/\u03b2 dual variable domain immunoglobulin, in knee osteoarthritis patients with synovitis","volume":"71","author":"Fleischmann","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100395_bib174","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1069057","article-title":"The potential roles of JAK\/STAT signaling in the progression of osteoarthritis","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.berh.2011.11.013","article-title":"Biomechanical factors in osteoarthritis","volume":"25","author":"Guilak","year":"2011","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.jtauto.2026.100395_bib176","article-title":"Recommendations for weight management in osteoarthritis: a systematic review of clinical practice guidelines","volume":"4","author":"Lim","year":"2022","journal-title":"Osteoarthr. Cartil. Open"},{"issue":"9","key":"10.1016\/j.jtauto.2026.100395_bib177","article-title":"Regenerative medicine for knee osteoarthritis\u2014the efficacy and safety of intra-articular platelet-rich plasma and mesenchymal stem cells injections: a literature review","volume":"12","author":"Ip","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib178","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10067-009-1301-1","article-title":"Is osteoarthritis a heterogeneous disease that can be stratified into subsets?","volume":"29","author":"Driban","year":"2010","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib179","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41584-018-0010-z","article-title":"The role of radiography and MRI for eligibility assessment in DMOAD trials of knee OA","volume":"14","author":"Roemer","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100395_bib180","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib181","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","article-title":"Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers consortium","volume":"76","author":"Kraus","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib182","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.berh.2014.01.007","article-title":"Biomarkers for osteoarthritis: current position and steps towards further validation","volume":"28","author":"Hunter","year":"2014","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jtauto.2026.100395_bib183","first-page":"295","article-title":"Clinical and omics biomarkers in osteoarthritis diagnosis and treatment","volume":"50","author":"Deng","year":"2025","journal-title":"J. Orthop. Transl."},{"issue":"Suppl 120","key":"10.1016\/j.jtauto.2026.100395_bib184","first-page":"64","article-title":"Phenotypes of osteoarthritis-current state and future implications","volume":"37","author":"Deveza","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib185","article-title":"The inflammatory endotype in osteoarthritis: reflections from the 2024 OARSI clinical trials symposium (CTS) with a special emphasis on feasibility for clinical development","volume":"7","author":"Karsdal","year":"2025","journal-title":"Osteoarthr. Cartil. Open"},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib186","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/annrheumdis-2021-221763","article-title":"Osteoarthritis endotype discovery via clustering of biochemical marker data","volume":"81","author":"Angelini","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jtauto.2026.100395_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.coph.2022.102213","article-title":"Targeting cellular senescence as a novel treatment for osteoarthritis","volume":"64","author":"Astrike-Davis","year":"2022","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jtauto.2026.100395_bib188","article-title":"Aging, cell senescence, the pathogenesis and targeted therapies of osteoarthritis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jtauto.2026.100395_bib189","article-title":"Immunomodulatory biomaterials for osteoarthritis: targeting inflammation and enhancing cartilage regeneration","author":"Zhao","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jtauto.2026.100395_bib190","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X231165558","article-title":"Strategic application of imaging in DMOAD clinical trials: focus on eligibility, drug delivery, and semiquantitative assessment of structural progression","volume":"15","author":"Guermazi","year":"2023","journal-title":"Ther. Adv. Musculoskel. Dis."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib191","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69328-w","article-title":"Detection of synovitis in early knee osteoarthritis by MRI and serum biomarkers in Japanese general population","volume":"10","author":"Ishibashi","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib192","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/s42003-025-08586-8","article-title":"A multi-tissue human knee single-cell atlas identifies that osteoarthritis reduces regenerative tissue stem cells while increasing inflammatory pain macrophages","volume":"8","author":"Raut","year":"2025","journal-title":"Commun. Biol."},{"issue":"731","key":"10.1016\/j.jtauto.2026.100395_bib193","doi-asserted-by":"crossref","first-page":"eadf4590","DOI":"10.1126\/scitranslmed.adf4590","article-title":"Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology","volume":"16","author":"Tang","year":"2024","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib194","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.joca.2024.11.002","article-title":"Longitudinal stability of molecular endotypes of knee osteoarthritis patients","volume":"33","author":"Hannani","year":"2025","journal-title":"Osteoarthr. Cartil."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib195","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13578-022-00786-7","article-title":"Heterogeneity of mesenchymal stem cell-derived extracellular vesicles is highly impacted by the tissue\/cell source and culture conditions","volume":"12","author":"Almeria","year":"2022","journal-title":"Cell Biosci."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib196","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcyt.2021.01.001","article-title":"Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles","volume":"23","author":"Gimona","year":"2021","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.jtauto.2026.100395_bib197","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/stcltm\/szad056","article-title":"Attitudes towards standardization of mesenchymal stromal cells\u2014a qualitative exploration of expert views","volume":"12","author":"Wilson","year":"2023","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.jtauto.2026.100395_bib198","unstructured":"Food, U., Potency Assurance for Cellular and Gene Therapy Products."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib199","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3390\/ijms25010394","article-title":"Advances in stem cell-based therapies in the treatment of osteoarthritis","volume":"25","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jtauto.2026.100395_bib200","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.biopha.2018.11.099","article-title":"Mesenchymal stem cell-based therapy of osteoarthritis: current knowledge and future perspectives","volume":"109","author":"Harrell","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jtauto.2026.100395_bib201","article-title":"Breaking the cycle: how immune reprogramming and modulation are redefining osteoarthritis care","author":"Afshari","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.jtauto.2026.100395_bib202","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1007\/s10787-025-02001-8","article-title":"Targeting the senescence-associated secretory phenotype to modify osteoarthritis in aging","volume":"33","author":"Afzal","year":"2025","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jtauto.2026.100395_bib203","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.joca.2021.02.077","article-title":"A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis","volume":"29","author":"Lane","year":"2021","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jtauto.2026.100395_bib204","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868343","article-title":"Trained immunity contribution to autoimmune and inflammatory disorders","volume":"13","author":"Funes","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jtauto.2026.100395_bib205","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/imr.13326","article-title":"Trained immunity: general and emerging concepts","volume":"323","author":"Vuscan","year":"2024","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.jtauto.2026.100395_bib206","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.joca.2020.01.007","article-title":"Macrophages regulate the progression of osteoarthritis","volume":"28","author":"Zhang","year":"2020","journal-title":"Osteoarthr. Cartil."},{"issue":"12","key":"10.1016\/j.jtauto.2026.100395_bib207","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.7150\/ijbs.115515","article-title":"Recent advances of trained immunity in macrophages","volume":"21","author":"Li","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jtauto.2026.100395_bib208","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.34133\/research.1097","article-title":"The gut microbiota: emerging evidence in autoimmune and inflammatory diseases","volume":"9","author":"Zeng","year":"2026","journal-title":"Research"},{"issue":"6","key":"10.1016\/j.jtauto.2026.100395_bib209","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.3390\/ijms25063242","article-title":"Role of the gut microbiota in osteoarthritis, rheumatoid arthritis, and spondylarthritis: an update on the gut\u2013joint axis","volume":"25","author":"Longo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jtauto.2026.100395_bib210","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.joca.2024.11.005","article-title":"Inflammaging contributes to osteoarthritis development and human microbiota variations and vice versa: a systematic review","volume":"33","author":"Gaspar","year":"2025","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jtauto.2026.100395_bib211","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1526690","article-title":"Clinical efficacy of probiotic supplementation in the treatment of knee osteoarthritis: a meta-analysis","volume":"16","author":"Tian","year":"2025","journal-title":"Front. Microbiol."}],"container-title":["Journal of Translational Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589909026000481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:47:26Z","timestamp":1793861246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589909026000481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":211,"alternative-id":["S2589909026000481"],"URL":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100395","relation":{},"ISSN":["2589-9090"],"issn-type":[{"value":"2589-9090","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune dysregulation in osteoarthritis: Mechanisms, biomarkers, and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Journal of Translational Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtauto.2026.100395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100395"}}